Other OTC - Delayed Quote • USD
NanoSphere Health Sciences Inc. (NSHSF)
At close: March 28 at 1:40 PM EDT
Breakdown
TTM
12/31/2022
12/31/2021
12/31/2020
Cost of Revenue
53.6940
--
--
--
Gross Profit
-328.0370
--
--
--
Operating Expense
289.9460
283.8760
386.0010
565.6250
Operating Income
-289.9460
-283.8760
-386.0010
-565.6250
Net Non Operating Interest Income Expense
--
--
0.0130
0.1530
Other Income Expense
23.2650
2.1240
29.7180
-25.7480
Pretax Income
-266.6810
-281.7520
-356.2700
-591.2200
Net Income Common Stockholders
-266.6810
-281.7520
-356.2700
-591.2200
Diluted NI Available to Com Stockholders
-266.6810
-281.7520
-356.2700
-591.2200
Basic EPS
-0.04
-0.03
-0.05
-0.11
Diluted EPS
-0.04
-0.03
-0.05
-0.11
Basic Average Shares
10,275.2050
10,275.2050
6,815.1000
5,417.7510
Diluted Average Shares
10,275.2050
10,275.2050
6,815.1000
5,417.7510
Rent Expense Supplemental
54.1040
--
--
--
Total Expenses
289.9460
283.8760
386.0010
565.6250
Interest Income
12.7170
--
0.0130
0.1530
Interest Expense
13.7530
--
-0.0130
-0.1530
Net Interest Income
--
--
0.0130
0.1530
Net Income from Continuing & Discontinued Operation
-266.6810
-281.7520
-356.2700
-591.2200
Normalized Income
-289.9460
-283.8760
-385.9880
-568.2010
EBIT
-289.9460
-283.8760
-386.0010
-565.6250
EBITDA
-289.9460
-283.8760
-386.0010
-551.8630
Reconciled Cost of Revenue
53.6940
--
--
--
Reconciled Depreciation
--
--
--
13.7620
Net Income from Continuing Operation Net Minority Interest
-266.6810
-281.7520
-356.2700
-591.2200
Total Unusual Items Excluding Goodwill
23.2650
2.1240
29.7180
-23.0190
Total Unusual Items
23.2650
2.1240
29.7180
-23.0190
Normalized EBITDA
-313.2110
-286.0000
-415.7190
-528.8440
12/31/2020 - 10/8/2009
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade